These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24844281)

  • 101. Identification of 17 Highly Expressed Genes within Mouse Lumbar Spinal Cord Anterior Horn Region from an In-Situ Hybridization Atlas of 3430 Genes: Implications for Motor Neuron Disease.
    Meyer MA
    Neurol Int; 2014 Apr; 6(2):5367. PubMed ID: 24987504
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Functional diversity of ESC-derived motor neuron subtypes revealed through intraspinal transplantation.
    Peljto M; Dasen JS; Mazzoni EO; Jessell TM; Wichterle H
    Cell Stem Cell; 2010 Sep; 7(3):355-66. PubMed ID: 20804971
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Degrading disease-causing RNA in ALS.
    Cully M
    Nat Rev Drug Discov; 2021 Dec; 20(12):897. PubMed ID: 34732854
    [No Abstract]   [Full Text] [Related]  

  • 104. PuraMatrix hydrogel enhances the expression of motor neuron progenitor marker and improves adhesion and proliferation of motor neuron-like cells.
    Darvishi M; Ghasemi Hamidabadi H; Sahab Negah S; Moayeri A; Tiraihi T; Mirnajafi-Zadeh J; Jahanbazi Jahan-Abad A; Shojaei A
    Iran J Basic Med Sci; 2020 Apr; 23(4):431-438. PubMed ID: 32489557
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Stem cells for amyotrophic lateral sclerosis modeling and therapy: myth or fact?
    Coatti GC; Beccari MS; Olávio TR; Mitne-Neto M; Okamoto OK; Zatz M
    Cytometry A; 2015 Mar; 87(3):197-211. PubMed ID: 25645594
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Human neural stem cell transplantation in ALS: initial results from a phase I trial.
    Mazzini L; Gelati M; Profico DC; Sgaravizzi G; Projetti Pensi M; Muzi G; Ricciolini C; Rota Nodari L; Carletti S; Giorgi C; Spera C; Domenico F; Bersano E; Petruzzelli F; Cisari C; Maglione A; Sarnelli MF; Stecco A; Querin G; Masiero S; Cantello R; Ferrari D; Zalfa C; Binda E; Visioli A; Trombetta D; Novelli A; Torres B; Bernardini L; Carriero A; Prandi P; Servo S; Cerino A; Cima V; Gaiani A; Nasuelli N; Massara M; Glass J; Sorarù G; Boulis NM; Vescovi AL
    J Transl Med; 2015 Jan; 13():17. PubMed ID: 25889343
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis.
    Oh KW; Moon C; Kim HY; Oh SI; Park J; Lee JH; Chang IY; Kim KS; Kim SH
    Stem Cells Transl Med; 2015 Jun; 4(6):590-7. PubMed ID: 25934946
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Transplantation of stem cell-derived astrocytes for the treatment of amyotrophic lateral sclerosis and spinal cord injury.
    Nicaise C; Mitrecic D; Falnikar A; Lepore AC
    World J Stem Cells; 2015 Mar; 7(2):380-98. PubMed ID: 25815122
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Early intervention for spinal cord injury with human induced pluripotent stem cells oligodendrocyte progenitors.
    All AH; Gharibani P; Gupta S; Bazley FA; Pashai N; Chou BK; Shah S; Resar LM; Cheng L; Gearhart JD; Kerr CL
    PLoS One; 2015; 10(1):e0116933. PubMed ID: 25635918
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Analysis of graft survival in a trial of stem cell transplant in ALS.
    Tadesse T; Gearing M; Senitzer D; Saxe D; Brat DJ; Bray R; Gebel H; Hill C; Boulis N; Riley J; Feldman E; Johe K; Hazel T; Polak M; Bordeau J; Federici T; Glass JD
    Ann Clin Transl Neurol; 2014 Nov; 1(11):900-8. PubMed ID: 25540804
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients.
    Abe K; Itoyama Y; Sobue G; Tsuji S; Aoki M; Doyu M; Hamada C; Kondo K; Yoneoka T; Akimoto M; Yoshino H;
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Dec; 15(7-8):610-7. PubMed ID: 25286015
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Glial-restricted precursors as potential candidates for ALS cell-replacement therapy.
    Kruminis-Kaszkiel E; Wojtkiewicz J; Maksymowicz W
    Acta Neurobiol Exp (Wars); 2014; 74(3):233-41. PubMed ID: 25231843
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Biological markers of mesenchymal stromal cells as predictors of response to autologous stem cell transplantation in patients with amyotrophic lateral sclerosis: an investigator-initiated trial and in vivo study.
    Kim HY; Kim H; Oh KW; Oh SI; Koh SH; Baik W; Noh MY; Kim KS; Kim SH
    Stem Cells; 2014 Oct; 32(10):2724-31. PubMed ID: 24966156
    [TBL] [Abstract][Full Text] [Related]  

  • 114. [Experimental approach to the gene therapy of motor neuron disease with the use of genes hypoxia-inducible factors].
    Ismailov ShM; Barykova IuA; Shmarov MM; Tarantul VZ; Barskov IV; Kucherianu VG; Brylev LV; Logunov DIu; Tutykhina IL; Bocharov EV; Zakharova MN; Naroditskiĭ BS; Illarioshkin SN
    Genetika; 2014 May; 50(5):591-601. PubMed ID: 25715475
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Intraspinal administration of human spinal cord-derived neural progenitor cells in the G93A-SOD1 mouse model of ALS delays symptom progression, prolongs survival and increases expression of endogenous neurotrophic factors.
    Knippenberg S; Rath KJ; Böselt S; Thau-Habermann N; Schwarz SC; Dengler R; Wegner F; Petri S
    J Tissue Eng Regen Med; 2017 Mar; 11(3):751-764. PubMed ID: 25641599
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?
    Mitsumoto H; Brooks BR; Silani V
    Lancet Neurol; 2014 Nov; 13(11):1127-1138. PubMed ID: 25316019
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial.
    Cudkowicz ME; Titus S; Kearney M; Yu H; Sherman A; Schoenfeld D; Hayden D; Shui A; Brooks B; Conwit R; Felsenstein D; Greenblatt DJ; Keroack M; Kissel JT; Miller R; Rosenfeld J; Rothstein JD; Simpson E; Tolkoff-Rubin N; Zinman L; Shefner JM;
    Lancet Neurol; 2014 Nov; 13(11):1083-1091. PubMed ID: 25297012
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Clinical relevance of stem cell therapies in amyotrophic lateral sclerosis.
    Srivastava AK
    Neurol India; 2014; 62(3):239-48. PubMed ID: 25033844
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Improvement in Spinal Cord Injury-Induced Bladder Fibrosis Using Mesenchymal Stem Cell Transplantation Into the Bladder Wall.
    Lee HJ; An J; Doo SW; Kim JH; Choi SS; Lee SR; Park SW; Song YS; Kim SU
    Cell Transplant; 2015; 24(7):1253-63. PubMed ID: 24912020
    [TBL] [Abstract][Full Text] [Related]  

  • 120. NurOwn, phase 2, randomized, clinical trial in patients with ALS: Safety, clinical, and biomarker results.
    Berry JD; Cudkowicz ME; Windebank AJ; Staff NP; Owegi M; Nicholson K; McKenna-Yasek D; Levy YS; Abramov N; Kaspi H; Mehra M; Aricha R; Gothelf Y; Brown RH
    Neurology; 2019 Dec; 93(24):e2294-e2305. PubMed ID: 31740545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.